PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Dermatology, Hospital General de Zona 32 Dr Mario Madrazo Navarro, Instituto Mexicano del Seguro Social, Mexico City, Mexico.\', \'Department of Immunology, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, 14080 Tlalpan, Mexico City, Mexico.\', \'Department of Immunology, Instituto Nacional de Cardiología Ignacio Chávez, Juan Badiano 1, Sección XVI, 14080 Tlalpan, Mexico City, Mexico. lmamezcuag@gmail.com.\', \'Department of Health Care, Universidad Autónoma Metropolitana Xochimilco, Mexico City, Mexico. lmamezcuag@gmail.com.\', \'Division of Musculoskeletal and Rheumatic Diseases, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City, Mexico.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s10067-021-05724-5
?:hasPublicationType
?:journal
  • Clinical rheumatology
is ?:pmid of
?:pmid
?:pmid
  • 33826045
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.93
?:rankingScore_hIndex
  • 71
is ?:relation_isRelatedTo_publication of
?:title
  • Are antiphospholipid antibodies just a common epiphenomenon or are they causative of immune-mediated coagulopathy in COVID-19?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all